Refractory Hypothyroidism: Unexpected Outcome During Treatment of Giant Cell Arteritis
Related Experiment Video
Updated: Jan 14, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Elise Deprince1, Solange Grunenwald1, Celine Mouly1
1Department of Endocrinology, Metabolic Diseases and Nutrition, Cardiovascular and Metabolic Unit Larrey University Hospital Toulouse France.
Abstract:
Refractory hypothyroidism is not uncommon in patients treated with oral levothyroxine, and it represents a challenge for clinicians as regards a physiopathological diagnosis and the most appropriate long-term therapeutic management in order to restore normal TSH concentrations.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Rheumatic Heart Disease I: Introduction
Desensitization and Tachyphylaxis

